Company presentations
Fy Cappa Biologics AG
We use a proprietary machine learning enabled discovery platform to create next-generation antibody product candidates designed to treat autoimmune and inflammatory diseases. Specifically, we focus on the portion of the antibody that interacts directly with the immune system, the Fc domain. Our rationally designed Fc domains can be readily substituted for natural Fc domains in existing or novel Antibody therapies, enhancing safety and efficacy.
Date, time and room information
May 6, 14:00 - 14:15, room Singapore
Category
Emerging biotech company
Title of the presentation
Fy Cappa Biologics: Engineering the Fc Landscape
Speaker information
| Name | Position | Institution |
|---|---|---|
| Andre Mercanzini | Co-Founder |
